Statins
Mostrando 1-12 de 177 artigos, teses e dissertações.
-
1. Há risco de incidência de Diabetes Mellitus tipo 2 (DM2) em doentes medicados com estatinas?
O uso de estatinas está associado a um aumento na ocorrência de diabetes
(OR 1,09; IC 95% (1,02a 1,17)
, especialmente em obesos, mulheres, idosos, descendentes de asiáticos, síndrome metabólica
, glicemia alta em jejum e com hemoglobina glicada alta (HbA1c > 6%). Em metanálise observou-se maior risco entre os doentes tratados com
Núcleo de Telessaúde Santa Catarina. Publicado em: 12/06/2023
-
2. Como manejar a interação entre anlodipino e sinvastatina?
Em pacientes que fazem uso de anlodipino e sinvastatina, a dose de sinvastatina não deve ultrapassar 20 mg por dia. Essa restrição deve-se ao risco de elevação do nível sérico de sinvastatina e ao aumento do risco de miopatia, incluindo rabdomiólise. O mecanismo dessa interação é incerto, mas pode envolver competição pelo CYP3A, pois os dois
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
3. Effects of statin response on cardiovascular outcomes in patients with ST-segment elevation myocardial infarction
SUMMARY OBJECTIVE: This study aimed to evaluate the effects of statin response on cardiovascular outcomes in patients with ST-segment elevation myocardial infarction. METHODS: A total of 1029 ST-segment elevation myocardial infarction patients were enrolled in the study. The patients who failed to achieve >40% reduction in baseline low-density lipoprotein
Revista da Associação Médica Brasileira. Publicado em: 2022
-
4. Comparison of cardiovascular risk calculators in patients with diabetes
SUMMARY OBJECTIVE: Cardiovascular risk stratification is an important clinical practice to estimate the severity of cardiovascular disease in patients with type 2 diabetes. This study aimed to compare the stratification of global cardiovascular risk with the specific risk stratification for patients with type 2 diabetes, seen at specialized outpatient clini
Rev. Assoc. Med. Bras.. Publicado em: 2021-02
-
5. Choosing statins: a review to guide clinical practice
ABSTRACT Statins are among the most widely prescribed medicines in the world and have proved their value in reducing cardiovascular events and mortality. Many patients report adverse effects that lead to interruption of treatment. This review aims to individualize statin treatment, considering efficacy for reducing cardiovascular risk and safety, in the sett
Arch. Endocrinol. Metab.. Publicado em: 2020-12
-
6. Choosing Wisely Statins
A avaliação, controle e gestão da pós-graduação no Brasil é promovida pela Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) e os programas que não possuem um plano estratégico formal desenvolvem suas ações baseadas no objetivo de cumprir com os requisitos do sistema de avaliação. O objetivo geral desta pesquisa é analisar
Arch. Endocrinol. Metab.. Publicado em: 2020-12
-
7. Treatment Eligibility and Therapeutic Responses of an Ecuadorian Population at High Cardiovascular Risk Based on the ATP III Guidelines
Abstract Background The Adult Treatment Panel III (ATPIII) guidelines aim to reduce cardiovascular morbidity and mortality. In Ecuador, 20% of people have high LDL cholesterol levels, and 39% have high triglyceride levels. Objective To analyze lipid-lowering regimens in Ecuadorian patients and determine the achievement rate of the ATPIII goals for lipid pr
Int. J. Cardiovasc. Sci.. Publicado em: 2020-07
-
8. Synergic effect of simvastatin in combination with amphotericin B against environmental strains of Cryptococcus neoformans from northeastern Brazil: a prospective experimental study
BACKGROUND: Statins are used as cholesterol-lowering drugs and may also have direct antimicrobial effects. OBJECTIVE: To evaluate synergic interactions between simvastatin and both amphotericin B and fluconazole, against environmental strains of Cryptococcus neoformans isolated from captive birds’ droppings. DESIGNAND SETTING: Experimental study cond
Sao Paulo Med. J.. Publicado em: 2020-02
-
9. Lack of association between dietary inflammatory index and low impact fractures in the Brazilian population: the Brazilian Osteoporosis Study (BRAZOS)
Abstract Introduction: Adequate nutrition, including intake of dietary calcium and vitamin D, is important to maintain bone health. Evidence suggests that a deficiency in micronutrients may contribute to bone loss during aging and exert generalized effects on chronic inflammation. Recently, the Dietary Inflammatory Index (DII) was developed to assess the in
Adv. rheumatol.. Publicado em: 29/07/2019
-
10. Do Not Treat Children with Statins
Arq. Bras. Cardiol.. Publicado em: 2019-03
-
11. PCSK9 Inhibitors: Clinical Relevance, Molecular Mechanisms, and Safety in Clinical Practice
Resumo A doença arterial coronariana (DAC) é uma das principais causas de mortalidade. Níveis circulantes elevados de lipoproteína de baixa densidade (LDL) no sangue estão associados com mortalidade cardiovascular, seja por um papel etiológico ou por sua associação com a progressão da DAC em si. Estudos clínicos randomizados mostram que, quando os
Arq. Bras. Cardiol.. Publicado em: 28/02/2019
-
12. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations
Dyslipidemia, diabetes, obesity and hypertension are common metabolic diseases. In the last decades, unhealthy lifestyle and aging have leads to an increased incidence of these diseases, increasing morbidity and mortality by cardiovascular causes. The treatment of metabolic diseases includes life-style interventions as healthy diet and physical exercise, as
Braz. J. Pharm. Sci.. Publicado em: 08/11/2018